PROFILE


Business Overview

Early Warning develops state-of-the art early warning systems that automatically and rapidly detect trace amounts of specific bacteria, viruses and parasitic protozoa. These pathogens can cause infections, disease and death when small concentrations are transmitted through water, food, surfaces, air, insects, animals, and people.
 
The key to preventing biohazard outbreaks is frequent and comprehensive testing for each suspected pathogen, as most occurrences of pathogens are not detected until after people get sick or die. Early Warning’s portable and wireless early warning systems are configured to the specific requirements of each application to provide a front line of defense against the transmission of deadly pathogens through automatic detection and automatic alerts. Over 25 scientists and engineers are involved in the development effort.
 
Early Warning expects to launch its water analyzers in late 2008. The early warning systems are configured to detect the presence of both common and rare strains of microorganisms associated with waterborne illnesses including E. coli (general and O157:H7), Cryptosporidium, Giardia, and various waterborne bacteria and viruses. Water agencies, food & beverage companies, industrial plants, hospitals, airlines, and recreational water facilities could use the portable and wireless water analyzers without needing a laboratory or technicians.
 
 

Early Warning has an exclusive license from NASA to commercialize its revolutionary nanotechnology-based biosensor developed for space applications. The biosensor works when a single strand of nucleic acid comes into contact with a matching strand of nucleic acid attached to the end of an ultra-conductive nanotube. The matching strands form a double helix that generates an electrical signal which is used to determine the presence of specific microorganisms in the sample. Because of their tiny size, millions of nanotubes can fit on a single biosensor chip allowing identification of very low levels.

Early Warning and NASA’s Ames Research Center in Silicon Valley have entered into a Space Act Agreement to develop biosensor enhancements over the next 5 years. 

 
 
Nanotechnology pioneers NASA’s Meyya Meyyappan, chief scientist for exploration technology and former director of the Center for Nanotechnology at Ames Research Center (left) and Early Warning’s President Neil Gordon examine a prototype of NASA’s nanotechnology-based biosensor licensed to Early Warning. (Source: NASA)